Serum paraoxonase and arylesterase can be useful markers to predict neoadjuvant chemotherapy requirement in patients with breast cancer.

Creative Commons License

Okuturlar Y. , Gunaldi M., Kocoglu H., Hursitoglu M., Gedikbasi A., Acarer D., et al.

Journal of cancer research and therapeutics, cilt.14, 2018 (SCI İndekslerine Giren Dergi)

  • Cilt numarası: 14
  • Basım Tarihi: 2018
  • Doi Numarası: 10.4103/0973-1482.235355
  • Dergi Adı: Journal of cancer research and therapeutics